规律使用润肤剂改善儿童特应性皮炎症状:一项随机对照研究
多中心随机平行组开放标签研究纳入335例轻中度特应性皮炎患儿,在急性发作经外用糖皮质激素缓解后按1:1:1随机分为V0034CR润肤剂组、参照润肤剂组和无润肤剂组治疗12周。V0034CR组和参照润肤剂组SCORAD评分分别较无润肤剂组多降低5.28分和3.36分(P均<0.001),完全缓解率分别为59.5%和44.3%,高于无润肤剂组的29.8%(P<0.001)。
要点
- 规律使用润肤剂可降低轻中度特应性皮炎患儿SCORAD评分。
- V0034CR组完全缓解率59.5%,参照润肤剂组44.3%,无润肤剂组29.8%。
- 润肤剂可作为轻中度特应性皮炎患儿的一线治疗。
核心结论
- 规律使用润肤剂可减轻轻中度特应性皮炎患儿的症状严重程度,支持其作为该类患者的一线治疗。
研究设计与样本
- 多中心随机、平行组、开放标签研究,纳入335例轻中度特应性皮炎患儿,在急性发作经外用糖皮质激素缓解后按1:1:1随机分为V0034CR润肤剂组(n=111)、参照润肤剂组(n=116)和无润肤剂组(n=108),治疗12周。
主要发现
- 治疗12周后,SCORAD评分在V0034CR组降低5.28分、参照润肤剂组降低3.36分,而无润肤剂组增加4分(两个润肤剂组 vs 无润肤剂组 P均<0.001)。
- PO-SCORAD评分在V0034CR组降低4.88分、参照润肤剂组降低2.67分,而无润肤剂组增加2.90分(P<0.001)。
- POEM评分观察到类似结果,12周治疗期间所有评分呈持续下降。
- 研究结束时完全缓解(治疗期间无新发急性发作)比例:V0034CR组59.5%、参照润肤剂组44.3%,高于无润肤剂组的29.8%(P<0.001)。
关键数值与推荐
- SCORAD评分较无润肤剂组多降低:V0034CR组5.28分,参照润肤剂组3.36分(P均<0.001)。
- 完全缓解率:V0034CR组59.5% vs 参照润肤剂组44.3% vs 无润肤剂组29.8%(P<0.001)。
临床怎么用
- 原文结论支持将规律使用润肤剂作为轻中度特应性皮炎患儿的一线治疗。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Emollients are considered as a first-line therapy for the treatment of atopic dermatitis (AD). However, evidence-based proof that the regular use of emollients reduces AD severity is lacking. OBJECTIVE: To assess whether the regular use of emollients results in a reduction in AD severity in children with AD. METHODS: In this multicentre randomized, parallel group, open-label study, children with mild-to-moderate AD were recruited during a flare. After flare resolution with a topical corticosteroid, patients were randomized to V0034CR emollient, reference emollient or no emollient (1:1:1 ratio), for 12 weeks. AD severity was assessed regularly by physicians [Scoring for Atopic Dermatitis (SCORAD) and subcomponents, IGA] and by parents (PO-SCORAD and POEM). RESULTS: A total of 335 patients were randomized to V0034CR (n = 111), reference emollient (n = 116) or no emollient (n = 108). After 12 weeks of treatment, SCORAD score was reduced by 5.28 points in the V0034CR group and by 3.36 points in the reference emollient group compared with the no emollient group (+4 points; P < 0.001 in both emollient groups vs. no emollient group). In a similar manner, PO-SCORAD score was reduced by 4.88 and 2.67 points in the V0034CR and reference emollient groups, respectively, but increased by 2.90 points in the no emollient group (P < 0.001). Similar results were observed for POEM. A continuous decrease in all scores was observed over the 12-week treatment period. At the end of the study, the percentage of patients in complete remission (i.e. without a new flare over the treatment period) was higher in the V0034CR (59.5%) and reference emollient (44.3%) groups than in the no emollient group (29.8%; P < 0.001). CONCLUSION: These results demonstrate that the regular use of emollients in children with mild-to-moderate AD reduces the severity of symptoms and, therefore, support their use as a first-line treatment for these patients.
引用
- Tiplica GS, Boralevi F, Konno P, et al. The regular use of an emollient improves symptoms of atopic dermatitis in children: a randomized controlled study. J Eur Acad Dermatol Venereol. 2018. PMID: 29419920. doi:10.1111/jdv.14849
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。